Cancer Genomics Consortium

The Cancer Genomics Consortium (CGC - cancergenomics.org) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Our vision is for all cancer patients to be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy. CGC aims to be the authoritative organization for guidance on the best practice of clinical cancer genomic testing. This YouTube channel makes selected presentations from Annual CGC Meetings available for public viewing. Please visit cancergenomics.org to become a member and gain full access to our complete library of presentations.

CGC Webinar: Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing

CGC Webinar: Transforming Tumor Methylation Profiling with Oxford Nanopore Direct DNA Sequencing
CGC Early Career Webinar: Digital Networking for Early Career Research and Clinical Professionals

CGC Early Career Webinar: Digital Networking for Early Career Research and Clinical Professionals
Clinical SNP-array adds value to diagnosis and surveillance of bone marrow failure syndromes

Clinical SNP-array adds value to diagnosis and surveillance of bone marrow failure syndromes
Challenges of classifying variants associated with disorders of somatic mosaicism

Challenges of classifying variants associated with disorders of somatic mosaicism
Prioritization of defining and supportive diagnostic variants in pediatric tumors

Prioritization of defining and supportive diagnostic variants in pediatric tumors
The clinical utility of the TSO500 clinically-verified test in patients with solid tumors

The clinical utility of the TSO500 clinically-verified test in patients with solid tumors
Significant copy number variants and loss of heterozygosity in Wilms Tumor

Significant copy number variants and loss of heterozygosity in Wilms Tumor
Integrated comprehensive genomic profiling of meningiomas: A single institutional study

Integrated comprehensive genomic profiling of meningiomas: A single institutional study
Current next generation sequencing reporting practices: a GOAL consortium report

Current next generation sequencing reporting practices: a GOAL consortium report
Invited Speaker: To a carpenter, every problem is a nail: FDA brings hammer to diagnostic medicine

Invited Speaker: To a carpenter, every problem is a nail: FDA brings hammer to diagnostic medicine
Invited Speaker: Cell-free DNA and AI technology for liquid biopsy detection of cancer early

Invited Speaker: Cell-free DNA and AI technology for liquid biopsy detection of cancer early
Somatic genomic testing & variant curation practices in Australian & New Zealand diagnostic testing

Somatic genomic testing & variant curation practices in Australian & New Zealand diagnostic testing
Keynote Presentation: Precision interception in multiple myeloma and it’s precursor conditions

Keynote Presentation: Precision interception in multiple myeloma and it’s precursor conditions
Classifying the oncogenicity of 100 variants from pediatric cancer patients

Classifying the oncogenicity of 100 variants from pediatric cancer patients
Methylation profiling more accurately predicts recurrence risk in meningiomas

Methylation profiling more accurately predicts recurrence risk in meningiomas
An evaluation of clinical significance of the TP53 polyadenylation signal-disrupting variant

An evaluation of clinical significance of the TP53 polyadenylation signal-disrupting variant
Clinical impact of in-house molecular testing for underserved cancer patients in southern Alabama

Clinical impact of in-house molecular testing for underserved cancer patients in southern Alabama
Methylation sequencing enhances interpretation of clonal hematopoiesis dynamics

Methylation sequencing enhances interpretation of clonal hematopoiesis dynamics
Ethnic and molecular disparities in prostate adenocarcinoma incidence: Data from 19 cohort studies

Ethnic and molecular disparities in prostate adenocarcinoma incidence: Data from 19 cohort studies
Invited Speaker: Interpretable & context-free deconvolution of multiscale transcriptomic lung cancer

Invited Speaker: Interpretable & context-free deconvolution of multiscale transcriptomic lung cancer
Invited Speaker Presentation: Current and Future Integrations of Genomics and AI

Invited Speaker Presentation: Current and Future Integrations of Genomics and AI
Keynote Presentation: The Grand Challenge of Cancer Disparities

Keynote Presentation: The Grand Challenge of Cancer Disparities
Implementation and utility of gene expression profile (GEP)-based classification

Implementation and utility of gene expression profile (GEP)-based classification
Best practices for testing and reporting of FISH studies in multiple myeloma

Best practices for testing and reporting of FISH studies in multiple myeloma
Contextualizing clinical significance using FDA label supplemented DGI data

Contextualizing clinical significance using FDA label supplemented DGI data
Enrichment of Hodgkin and Reed-Sternberg (HRS) cells using size-based microfiltration

Enrichment of Hodgkin and Reed-Sternberg (HRS) cells using size-based microfiltration
CGC 2024 Keynote Presentation-Enabling clinical translation of high-throughput functional assay data

CGC 2024 Keynote Presentation-Enabling clinical translation of high-throughput functional assay data
Using ClinVar to Share Germline & Somatic Variant Classifications from Clinical Genomic Testing

Using ClinVar to Share Germline & Somatic Variant Classifications from Clinical Genomic Testing
Exhibitor Showcase: Thermo Fisher

Exhibitor Showcase: Thermo Fisher
Exhibitor Showcase: Natera

Exhibitor Showcase: Natera